90 related articles for article (PubMed ID: 16052363)
1. Impaired platelet [3H]paroxetine binding in female patients with borderline personality disorder.
Ng Ying Kin NM; Paris J; Schwartz G; Zweig-Frank H; Steiger H; Nair NP
Psychopharmacology (Berl); 2005 Nov; 182(3):447-51. PubMed ID: 16052363
[TBL] [Abstract][Full Text] [Related]
2. Platelet [³H] paroxetine binding in female patients with borderline personality disorder and their sisters.
Paris J; Laporte L; Russell J; Ng Ying Kin N; Guttman H
Psychiatry Res; 2011 Mar; 186(1):76-9. PubMed ID: 20832123
[TBL] [Abstract][Full Text] [Related]
3. Childhood abuse and platelet tritiated-paroxetine binding in bulimia nervosa: implications of borderline personality disorder.
Steiger H; Léonard S; Kin NY; Ladouceur C; Ramdoyal D; Young SN
J Clin Psychiatry; 2000 Jun; 61(6):428-35. PubMed ID: 10901341
[TBL] [Abstract][Full Text] [Related]
4. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet.
Coccaro EF; Kavoussi RJ; Sheline YI; Lish JD; Csernansky JG
Arch Gen Psychiatry; 1996 Jun; 53(6):531-6. PubMed ID: 8639036
[TBL] [Abstract][Full Text] [Related]
5. Platelet serotonin and [3H]paroxetine binding correlate with recurrence of suicidal behavior.
Verkes RJ; Fekkes D; Zwinderman AH; Hengeveld MW; Van der Mast RC; Tuyl JP; Kerkhof AJ; Van Kempen GM
Psychopharmacology (Berl); 1997 Jul; 132(1):89-94. PubMed ID: 9272764
[TBL] [Abstract][Full Text] [Related]
6. Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls.
Hoerst M; Weber-Fahr W; Tunc-Skarka N; Ruf M; Bohus M; Schmahl C; Ende G
Arch Gen Psychiatry; 2010 Sep; 67(9):946-54. PubMed ID: 20603446
[TBL] [Abstract][Full Text] [Related]
7. Further studies on platelet serotonin transporter binding in depression.
Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
[TBL] [Abstract][Full Text] [Related]
8. Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls.
Paris J; Zweig-Frank H; Kin NM; Schwartz G; Steiger H; Nair NP
Psychiatry Res; 2004 Jan; 121(3):239-52. PubMed ID: 14675743
[TBL] [Abstract][Full Text] [Related]
9. Serotonin function, personality-trait variations, and childhood abuse in women with bulimia-spectrum eating disorders.
Steiger H; Gauvin L; Israël M; Kin NM; Young SN; Roussin J
J Clin Psychiatry; 2004 Jun; 65(6):830-7. PubMed ID: 15291661
[TBL] [Abstract][Full Text] [Related]
10. Psychobiology of borderline personality traits related to subtypes of eating disorders: a study of platelet MAO activity.
Díaz-Marsá M; Carrasco JL; de Anta L; Molina R; Sáiz J; Cesar J; López-Ibor JJ
Psychiatry Res; 2011 Dec; 190(2-3):287-90. PubMed ID: 21658781
[TBL] [Abstract][Full Text] [Related]
11. Affective lability in bipolar disorder and borderline personality disorder.
Reich DB; Zanarini MC; Fitzmaurice G
Compr Psychiatry; 2012 Apr; 53(3):230-7. PubMed ID: 21632042
[TBL] [Abstract][Full Text] [Related]
12. 5HT2A receptor binding is increased in borderline personality disorder.
Soloff PH; Price JC; Meltzer CC; Fabio A; Frank GK; Kaye WH
Biol Psychiatry; 2007 Sep; 62(6):580-7. PubMed ID: 17448449
[TBL] [Abstract][Full Text] [Related]
13. Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy.
Smedh K; Spigset O; Allard P; Mjörndal T; Adolfsson R
Biol Psychiatry; 1999 Feb; 45(4):464-70. PubMed ID: 10071719
[TBL] [Abstract][Full Text] [Related]
14. Borderline personality disorder in male and female offenders newly committed to prison.
Black DW; Gunter T; Allen J; Blum N; Arndt S; Wenman G; Sieleni B
Compr Psychiatry; 2007; 48(5):400-5. PubMed ID: 17707246
[TBL] [Abstract][Full Text] [Related]
15. The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes.
Steiger H; Joober R; Israël M; Young SN; Ng Ying Kin NM; Gauvin L; Bruce KR; Joncas J; Torkaman-Zehi A
Int J Eat Disord; 2005 Jan; 37(1):57-60. PubMed ID: 15690467
[TBL] [Abstract][Full Text] [Related]
16. [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects.
Koch W; Schaaff N; Pöpperl G; Mulert C; Juckel G; Reicherzer M; Ehmer-von Geiso C; Möller HJ; Hegerl U; Tatsch K; Pogarell O
J Psychiatry Neurosci; 2007 Jul; 32(4):234-40. PubMed ID: 17653291
[TBL] [Abstract][Full Text] [Related]
17. Platelet serotonin measures in primary dysthymia.
Ravindran AV; Chudzik J; Bialik RJ; Lapierre YD; Hrdina PD
Am J Psychiatry; 1994 Sep; 151(9):1369-71. PubMed ID: 8067494
[TBL] [Abstract][Full Text] [Related]
18. Borderline personality-bipolar spectrum relationship.
Benazzi F
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):68-74. PubMed ID: 16019119
[TBL] [Abstract][Full Text] [Related]
19. Metabolic alterations in the amygdala in borderline personality disorder: a proton magnetic resonance spectroscopy study.
Hoerst M; Weber-Fahr W; Tunc-Skarka N; Ruf M; Bohus M; Schmahl C; Ende G
Biol Psychiatry; 2010 Mar; 67(5):399-405. PubMed ID: 19931853
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
Faludi G; Tekes K; Tóthfalusi L
J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
